The Oxford Vaccine Group conducts laboratory and clinical research in many different areas related to infectious diseases and vaccination in childhood as well as adulthood. Below you can browse all the different areas we investigate.
The fraudulent research paper authored by Andrew Wakefield and published in The Lancet claimed to link the vaccine to colitis and autism spectrum disorders. The paper was retracted in 2010 but is still cited by anti-vaccinationists. The claims in the paper were widely reported, leading to a sharp drop in vaccination rates in the UK and Ireland.
The Science Behind Vaccine Research and Testing How Vaccines Are Made And Tested. The creation of a vaccine involves scientists and medical experts from around the world, and it usually requires 10 to 15 years of research before the vaccine is made available to the general public. The first step of this extensive process involves several years of laboratory research, in which scientists and.
Although the paper said that no causal connection had been proven, before it was published, Wakefield made statements at a press conference and in a video news release issued by the hospital, calling for suspension of the triple MMR vaccine until more research could be done. This was later criticized as 'science by press conference'.
It comes after Dr Andrew Wakefield, the lead researcher in the 1998 paper, was ruled last week to have broken research rules by the General Medical Council. The publication caused vaccination rates to plummet, resulting in a rise in measles. The Lancet had already issued a partial retraction.
Predictive value of seizure ICD-9 codes for vaccine safety research. external icon Vaccine. 2009 Aug;27(39):5307-12. Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. external icon JAMA. 2009 Aug;302(7):750-7.
Several groups in Edinburgh addressing are how pathogens evade immune attack and how they can modulate and modify host immunity to their own advantage. There are also a number of researchers investigating the modes of immune responsiveness most effective at resolving infection, and how molecular vaccines can be used in human and animal health to stimulate protective immunity.
The newly established Vaccine Research Center (VRC) was dedicated to immunization advocates Dale and Betty Bumpers. 2000 NIAID formed the HIV Vaccine Trials Network (HVTN), a network of clinical sites in the United States and abroad dedicated to developing a preventive HIV vaccine by testing and evaluating candidate vaccines in all phases of clinical trials.